Study of XL418 in Adults With Solid Tumors

Summary

The purpose of this study is to evaluate the safety and tolerability of XL418 in subjects with solid tumors. XL418 is a new chemical entity that inhibits a spectrum of targets, including Akt and p70S6K, that mediate PI3 Kinase / PTEN signaling.

Timeline

Start

2007-04

Primary completion

—

Completion

—

Outcome

Outcome not reported

Stopped (Enrollment): “Enrollment suspended due to low drug exposure.”

Drugs

Indications